Review of NICE Technology Appraisal Guidance No.64; Human growth hormone (somatropin) in adults with growth hormone deficiency

Decision to defer the review

The planned date for review of the above guidance was early 2012.  

This is the date at which the Institute decides whether sufficient new evidence has emerged for the Appraisal Committee to be asked to undertake a full review appraisal.

In June 2009, the decision was made to defer the review proposal of TA64 until early 2012, when the results of a trial were expected to be published.  The results from this are not yet available.  NICE will continue to monitor the trial and a review proposal will be issued within 6 months of the publication of the trial results.

May 2012